Machine learning and novel ophthalmologic biomarkers for Alzheimer’s disease screening: Systematic Review

Hind Bourkhime,Noura Qarmiche,Mohammed Omari,Nassiba Bahra,Nabil Tachfouti,Samira EL Fakir,Nada Otmani

DOI: https://doi.org/10.1051/itmconf/20224301009

2022-01-01

ITM Web of Conferences

Abstract:Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disease that leads to dementia and eventual death, the reason why screening is so beneficial in its early stages. Recent evidence suggests that memory and vision impairments are closely linked to Alzheimer’s disease. Moreover, assessing vision disorders may improve early detection and treatment of dementia. Therefore, some research has been conducted on screening for AD disease using new machine learning (ML) techniques on novel ophthalmologic biomarkers data. Objective: To summarize existing findings on machine learning models exploring eye changes data to predict cognitive decline in the context of AD. Methods: Systematic review of original research between January 2016 and August 2021. A search covered two databases on (Scopus) and (PubMed). Results: From 104 search results, 13 articles were selected after using the eligibility criteria: 5 machine learning models used retinal texture data, 5 models included eye movement data, 2 proposed models used iris change data, and 1 proposed model used corneal nerve loss data. Conclusion: Promising results are reported in almost all 13 studies, but very few have been implemented in research or clinical practice. The principal constraints in this area are limited standardization and comparability of results..